Navigation Links
Champions Oncology Reports Financial Results for the Quarter Ended October 31, 2012
Date:12/13/2012

1,354

945Cost of TOS

475

620

1,174

1,104Research and development

436

1,008

823

1,616Sales and marketing

680

651

1,389

1,262General and administrative

1,201

1,470

2,340

3,130  Loss from Operations($1,916)($2,469)($3,516)($4,685)Other (Loss) Income

(57)

120

223

298  Net Loss before income tax expense($1,973)($2,349)($3,293)($4,387)Income taxes

1

-

4

-  Net Loss($1,974)($2,349)($3,297)($4,387)  Earnings per share- basic and diluted($0.04)($0.05)($0.07)($0.09)Weighted average shares outstanding- basic and diluted

47,079,000

46,790,000

47,073,000

46,606,000 Condensed Consolidated Balance Sheets Balance as of  October 31, 2012(unaudited)April 30, 2012 Cash and cash equivalents

$2,161

$4,716Accounts receivable

627

584Other current assets

95

205  Total current assets2,8835,505Restricted cash

188

188Property and equipment, net

485

560Goodwill

669

669  Total assets$4,225$6,922Accounts payable and accrued liabilities

$1,723

$2,301Deferred revenue

1,205

1,185  Total current liabilities2,9283,486Warrant liability

322

555Redeemable common stock

8,159

8,159Stockholders' deficit

(7,184)

(5,278)  Total liabilities, redeemable common stock andstockholders' deficit$4,225$6,922 Condensed Consolidated Statements of Cash Flows (Unaudited)Six Months Ended October 31,20122011Cash flows from operating activities:Net Loss

($3,297)

($4,387)Adjustments to reconcile net cash used in operations:  Stock-based compensation expense

1,364

1,868
'/>"/>

SOURCE Champions Oncology, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities
2. Champions Oncology Reports Financial Results for the Year Ended April 30, 2012
3. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
4. OvaGene Oncology Collaborates With Moffitt Cancer Center to Develop and Commercialize microRNAs Associated With Chemotherapeutic Drug Response
5. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
6. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
7. 500 Oncology Providers Sign Up for Navigating Cancers Patient Engagement Portal
8. Symphogen Grants Exclusive Worldwide License of Phase II Oncology Drug Candidate Sym004 to Merck KGaA
9. New Boehringer Ingelheim Oncology Data to be Presented at ESMO 2012 Congress
10. International Oncology Innovators Meeting in Hamburg
11. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Milpitas, CA (PRWEB) March 02, 2015 ... chain events annual report which summarizes and ... generated by its EventWatch™ 24X7 global event ... practitioners can subscribe to a free trial period of ... of supply chain incidents that can negatively impact revenue, ...
(Date:3/2/2015)... GAITHERSBURG, Md. , March 2, 2015 /PRNewswire/ ... Gaithersburg -based biotechnology company focusing on the ... and next generation antibody agents based upon a ... received a 2015 Life Sciences Impact Grant Award ... (MCDED).  The grant, created by MCDED, is awarded ...
(Date:3/2/2015)... March 2, 2015  Pfenex Inc. (NYSE MKT: ... development of biosimilar therapeutics, today announced that it ... Healthcare Conference in Miami, FL at the Loews Miami Beach ... officer of Pfenex, will provide an overview of ... 12th at 9:00 am ET. A live audio webcast and ...
(Date:3/2/2015)... , March 2, 2015 Editor ... bottom.   Moments ago, Analysts Review released ... Sunshine Heart (NASDAQ: SSH ), Synergetics ... Medical (NASDAQ: ELOS ), Spectranetics (NASDAQ: ... Review provides a single unified platform for investors, to hear ...
Breaking Biology Technology:Resilinc Publishes 2014 EventWatch™ Supply Chain Disruption Annual Report 2Resilinc Publishes 2014 EventWatch™ Supply Chain Disruption Annual Report 3VLP Therapeutics Wins the 2015 Life Sciences Impact Grant Award from the Montgomery County Department of Economic Development 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 3Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 4
... , ... easiest, and most consistent method for PAGE purification of small , ... which was designed for the visualization of small nucleic acids, the flashPAGE , ... and DNA. , ...
... Orders of magnitude better DNA , ... Perform DNA digestion and sample , ... Preserve RNA quality , ... the removal of contaminating genomic DNA from RNA samples in , ...
... Ambion now offers an improved MessageAmp ... with biotin-11-UTP. MessageAmp II-Biotin Enhanced , ... array analysis. The biotin modified UTP and ratio of labeled ... UTP were selected based on superior performance , ...
Cached Biology Technology:Ultra-Fast Purification of Small Nucleic Acids 2Ultra-Fast Purification of Small Nucleic Acids 3Ultra-Fast Purification of Small Nucleic Acids 4Ultra-Fast Purification of Small Nucleic Acids 5The Fastest, Simplest, and Most Effective Way to Remove DNA Contamination 2The Fastest, Simplest, and Most Effective Way to Remove DNA Contamination 3Synthesize High Yields of Biotinylated aRNA 2Synthesize High Yields of Biotinylated aRNA 3Synthesize High Yields of Biotinylated aRNA 4Synthesize High Yields of Biotinylated aRNA 5Synthesize High Yields of Biotinylated aRNA 6Synthesize High Yields of Biotinylated aRNA 7
(Date:1/22/2015)... , Jan. 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: ... market in general the State of Washington,s ... for a new enrollment and central issuance system for driver,s ... The project planning and development will start in ...
(Date:1/22/2015)...  Today, FreeWavz ( www.FreeWavz.com ), the developer of ... Fundable, https://www.fundable.com/freewavz . FreeWavz will be expanding ... meet customer demand. Logo - ... Invented by Dr. Eric ...
(Date:1/22/2015)... MADISON, Wis. , Jan. 15, 2015  BellBrook ... for drug discovery, announced the launch of a ... of the company,s Transcreener UDP Assay, a high ... enzymes. The new assay will allow for sensitive ...
Breaking Biology News(10 mins):Valid USA Signs Contract For Washington Driver's License Issuance 2FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2
... Can superheroes teach us about neuroscience? How does ... Russia? Why does global warming cause energy use to ... Victoria researchers will answer those and many other questions ... of Science annual meeting at the Vancouver Conference Centre ...
... drugs with cheaper generic equivalents has been an ... and people with epilepsy. The U.S. Food ... the same dosage, purity and strength as their ... doctors and people with epilepsy remain concerned, citing ...
... Routledge will share his knowledge of what layers of ... area,s forest fire history, at the world,s largest science ... Fires in Canada: Impacts of Climate Change and Fire ... for the Advancement of Science (AAAS) conference. The international ...
Cached Biology News:UVic researchers among presenters at global science conference 2Switching antiepileptic drugs could increase risk of seizures 2Switching antiepileptic drugs could increase risk of seizures 3Switching antiepileptic drugs could increase risk of seizures 4AAAS-SFU research: Controlling forest fires 2
Standard 2" and 3" Fiberboard Boxes can be sold separately or with 16, 25, 36, 49, 64, 81 or 100 cell dividers. Fiberboard boxes can also be ordered with corresponding freezer racks...
Borosilicate Glass. Certified for use with the Beacon 2000 Systems, 1,000 tubes/case...
Whole blood is collected from mice (Swiss Webster, 8-10 weeks old,either sex) and processed within 45 minutes of collection. The complement is then filtered and pooled on ice, bottled and stored at -...
... technology incorporating the sophisticated DirectDrive architecture ... new Varian NMR System is undeniably ... ,The Varian NMR System features parallel ... channel, providing pulse sequence programming power ...
Biology Products: